Cardio-oncology & other

Prevalence and Clinical Impact of Postural Orthostatic Tachycardia Syndrome in Highly Symptomatic Long COVID

Circ Arrhythm ElectrophysiolPublished prospective analysis

Authors' conclusion

In this cohort of predominantly younger women with highly symptomatic long COVID, POTS is common and presents with overlapping symptoms between POTS and non-POTS patients. Long COVID POTS confers lower physical activity and capacity compared with non-POTS long COVID and should be systematically assessed in this condition.

Study context

Population
Nonhospitalized, highly symptomatic (sick leave ≥50%) patients with long COVID
Participants
467 participants
Exposure
Those diagnosed with postural orthostatic tachycardia syndrome (POTS) and the remaining long COVID patients
  • POTSn = 143
  • Did not fulfill POTS criterian = 128
  • No clinical signs of POTSn = 196
Outcome
Diagnosis of POTS
Follow-up
Median of 12 months after acute COVID-19

Main finding

As reported in the abstract

Observational data: associations, not effects.

Further findings

Age

6-minute walk distance

OutcomePOTSDid not fulfill POTS criteriaNo clinical signs of POTS
Female sex91%Not reported in the abstractNot reported in the abstractdid not fulfill POTS criteria, no clinical signs of POTS: not reported in the abstract
Age — P
P ≤0.001
6-minute walk distance — P
P ≤0.001

Physical activity (Frändin-Grimby scale)

Significantly lower physical activity in POTS compared with the other 2 groups
P = 0.001

Heart rate during 6-minute walk test

Significantly higher in the POTS group, both during walking and at rest afterward

Distribution of symptoms

No significant differences between the groups

Original publication

Prevalence and Clinical Impact of Postural Orthostatic Tachycardia Syndrome in Highly Symptomatic Long COVID. Circ Arrhythm Electrophysiol. Published 30 September 2025. doi:10.1161/circep.124.013629

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.